Article Details

Leerink Swann Lowers Adaptimmune Therapeutics (ADAP) to Market Perform

Retrieved on: 2019-05-10 01:05:38

Tags for this article:

Click the tags to see associated articles and topics

Leerink Swann Lowers Adaptimmune Therapeutics (ADAP) to Market Perform. View article details on hiswai:

Excerpt

<div>Finally, <b>Acadian Asset Management</b> LLC purchased a new stake in shares of Adaptimmune Therapeutics during the 4th quarter valued at about ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo